Abstract
Obsessive-compulsive disorder (OCD) is phenotypically heterogeneous and genetically complex. This study aimed to reduce heterogeneity using structural brain imaging to study putative intermediate phenotypes for OCD. We hypothesized that select serotonin gene variants would differ in their relationship with brain volume in specific regions of the cortico-striato-thalamo-cortical (CSTC) circuits between OCD patients and controls. In a total of 200 pediatric subjects, we genotyped candidate serotonin genes (SLC6A4, HTR2A, HTR1B, and HTR2C) and conducted structural magnetic resonance imaging (sMRI) to measure regional brain volumes within CSTC circuits. In males and females separately, we first tested the association between serotonin gene variants and OCD and the effect of serotonin gene variants on brain volume irrespective of diagnosis. We then carried out a series of analyses to assess the effect of genotype-diagnosis interaction on brain volume. In females, but not in males, we identified a statistically significant genotype-diagnosis interaction for two single nucleotide polymorphisms (SNPs) in HTR2C, rs12860460 (interaction term estimate of 5.45 cc and interaction P value of 9.70e-8) and rs12854485 (interaction term estimate of 4.28 cc and interaction P value of 2.07e-6). The tested allele in each SNP was associated with decreased anterior cingulate cortex (ACC) volume in controls and with increased ACC volume in OCD patients. Our findings suggest that, in females, sequence variation in HTR2C influences ACC volume in pediatric OCD. The variants may contribute to differences in ACC volume and to OCD in a sex-specific manner when acting together with other genetic, biological, and/or environmental factors.
Similar content being viewed by others
References
Alvarenga, P. G., Cesar, R. C., Leckman, J. F., Moriyama, T. S., Torres, A. R., Bloch, M. H., Coughlin, C. G., Hoexter, M. Q., Manfro, G. G., Polanczyk, G. V., Miguel, E. C., & do Rosario, M. C. (2015). Obsessive-compulsive symptom dimensions in a population-based, cross-sectional sample of school-aged children. Journal of Psychiatric Research, 62, 108–114.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC.
American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA.
Arnold, P., & Richter, M. A. (2007). Genetics of obsessive-compulsive disorder: Evidence from pediatric and adult studies. In E. A. Storch & G. R. Greffken (Eds.), Handbook of child and adolescent obsessive-compulsive disorder. New Jersey: Lawrence Erlbaum Associates Inc..
Arnold, P. D., MacMaster, F. P., Hanna, G. L., Richter, M. A., Sicard, T., Burroughs, E., Mirza, Y., Easter, P. C., Rose, M., Kennedy, J. L., & Rosenberg, D. R. (2009). Glutamate system genes associated with ventral prefrontal and thalamic volume in pediatric obsessive-compulsive disorder. Brain Imaging and Behavior, 3(1), 64–76.
Atmaca, M., Onalan, E., Yildirim, H., Yuce, H., Koc, M., Korkmaz, S., & Mermi, O. (2011). Serotonin transporter gene polymorphism implicates reduced orbito-frontal cortex in obsessive-compulsive disorder. Journal of Anxiety Disorders, 25(5), 680–685.
Bloch, M. H., Landeros-Weisenberger, A., Rosario, M. C., Pittenger, C., & Leckman, J. F. (2008). Meta-analysis of the symptom structure of obsessive-compulsive disorder. The American Journal of Psychiatry, 165(12), 1532–1542.
Boedhoe, P. S., Schmaal, L., Abe, Y., Ameis, S. H., Arnold, P. D., Batistuzzo, M. C., Benedetti, F., Beucke, J. C., Bollettini, I., Bose, A., Brem, S., Calvo, A., Cheng, Y., Cho, K. I., Dallaspezia, S., Denys, D., Fitzgerald, K. D., Fouche, J. P., Giménez, M., Gruner, P., Hanna, G. L., Hibar, D. P., Hoexter, M. Q., Hu, H., Huyser, C., Ikari, K., Jahanshad, N., Kathmann, N., Kaufmann, C., Koch, K., Kwon, J. S., Lazaro, L., Liu, Y., Lochner, C., Marsh, R., Martínez-Zalacaín, I., Mataix-Cols, D., Menchón, J. M., Minuzzi, L., Nakamae, T., Nakao, T., Narayanaswamy, J. C., Piras, F., Piras, F., Pittenger, C., Reddy, Y. C., Sato, J. R., Simpson, H. B., Soreni, N., Soriano-Mas, C., Spalletta, G., Stevens, M. C., Szeszko, P. R., Tolin, D. F., Venkatasubramanian, G., Walitza, S., Wang, Z., van Wingen, G. A., Xu, J., Xu, X., Yun, J. Y., Zhao, Q., ENIGMA OCD Working Group, Thompson, P. M., Stein, D. J., & van den Heuvel, O. A. (2017). Distinct subcortical volume alterations in pediatric and adult OCD: A worldwide Meta- and mega-analysis. American Journal of Psychiatry, 174(1), 60–69.
Brem, S., Hauser, T. U., Iannaccone, R., Brandeis, D., Drechsler, R., & Walitza, S. (2012). Neuroimaging of cognitive brain function in paediatric obsessive compulsive disorder: A review of literature and preliminary meta-analysis. Journal of Neural Transmission (Vienna), 119(11), 1425–1448.
Carter, C. S., Bearden, C. E., Bullmore, E. T., Geschwind, D. H., Glahn, D. C., Gur, R. E., Meyer-Lindenberg, A., & Weinberger, D. R. (2017). Enhancing the informativeness and replicability of imaging genomics studies. Biological Psychiatry, 82(3), 157–164.
Davis, L. K., Yu, D., Keenan, C. L., Gamazon, E. R., Konkashbaev, A. I., Derks, E. M., Neale, B. M., Yang, J., Lee, S. H., Evans, P., Barr, C. L., Bellodi, L., Benarroch, F., Berrio, G. B., Bienvenu, O. J., Bloch, M. H., Blom, R. M., Bruun, R. D., Budman, C. L., Camarena, B., Campbell, D., Cappi, C., Cardona, Silgado, J. C., Cath, D. C., Cavallini, M. C., Chavira, D. A., Chouinard, S., Conti, D. V., Cook, E. H., Coric, V., Cullen, B. A., Deforce, D., Delorme, R., Dion, Y., Edlund, C. K., Egberts, K., Falkai, P., Fernandez, T. V., Gallagher, P. J., Garrido, H., Geller, D., Girard, S. L., Grabe, H. J., Grados, M. A., Greenberg, B. D., Gross-Tsur, V., Haddad, S., Heiman, G. A., Hemmings, S. M., Hounie, A. G., Illmann, C., Jankovic, J., Jenike, M. A., Kennedy, J. L., King, R. A., Kremeyer, B., Kurlan, R., Lanzagorta, N., Leboyer, M., Leckman, J. F., Lennertz, L., Liu, C., Lochner, C., Lowe, T. L., Macciardi, F., McCracken, J. T., McGrath, L. M., Mesa Restrepo, S. C., Moessner, R., Morgan, J., Muller, H., Murphy, D. L., Naarden, A. L., Ochoa, W. C., Ophoff, R. A., Osiecki, L., Pakstis, A. J., Pato, M. T., Pato, C. N., Piacentini, J., Pittenger, C., Pollak, Y., Rauch, S. L., Renner, T. J., Reus, V. I., Richter, M. A., Riddle, M. A., Robertson, M. M., Romero, R., Rosàrio, M. C., Rosenberg, D., Rouleau, G. A., Ruhrmann, S., Ruiz-Linares, A., Sampaio, A. S., Samuels, J., Sandor, P., Sheppard, B., Singer, H. S., Smit, J. H., Stein, D. J., Strengman, E., Tischfield, J. A., Valencia Duarte, A. V., Vallada, H., Van Nieuwerburgh, F., Veenstra-Vanderweele, J., Walitza, S., Wang, Y., Wendland, J. R., Westenberg, H. G., Shugart, Y. Y., Miguel, E. C., McMahon, W., Wagner, M., Nicolini, H., Posthuma, D., Hanna, G. L., Heutink, P., Denys, D., Arnold, P. D., Oostra, B. A., Nestadt, G., Freimer, N. B., Pauls, D. L., Wray, N. R., Stewart, S. E., Mathews, C. A., Knowles, J. A., Cox, N. J., & Scharf, J. M. (2013). Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genetics, 9(10), e1003864.
Delaneau, O., Marchini, J., & 1000 Genomes Project Consortium. (2014). Integrating sequence and array data to create an improved 1000 genomes project haplotype reference panel. Nature Communications, 5, 3934.
Di Narzo, A. F., Kozlenkov, A., Roussos, P., Hao, K., Hurd, Y., Lewis, D. A., Sibille, E., Siever, L. J., Koonin, E., & Dracheva, S. (2014). A unique gene expression signature associated with serotonin 2C receptor RNA editing in the prefrontal cortex and altered in suicide. Human Molecular Genetics, 23(18), 4801–4813.
Dracheva, S., Patel, N., Woo, D. A., Marcus, S. M., Siever, L. J., & Haroutunian, V. (2008). Increased serotonin 2C receptor mRNA editing: A possible risk factor for suicide. Molecular Psychiatry, 13(11), 1001–1010.
Fagerberg, L., Hallstrom, B. M., Oksvold, P., Kampf, C., Djureinovic, D., Odeberg, J., Habuka, M., Tahmasebpoor, S., Danielsson, A., Edlund, K., Asplund, A., Sjöstedt, E., Lundberg, E., Szigyarto, C. A., Skogs, M., Takanen, J. O., Berling, H., Tegel, H., Mulder, J., Nilsson, P., Schwenk, J. M., Lindskog, C., Danielsson, F., Mardinoglu, A., Sivertsson, A., von Feilitzen, K., Forsberg, M., Zwahlen, M., Olsson, I., Navani, S., Huss, M., Nielsen, J., Ponten, F., & Uhlen, M. (2014). Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Molecular & Cellular Proteomics : MCP, 13(2), 397–406.
Gelernter, J., Kranzler, H., & Cubells, J. F. (1997). Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in african- and european-american and japanese populations and in alcohol-dependent subjects. Human Genetics, 101(2), 243–246.
Grados, M. A. (2010). The genetics of obsessive-compulsive disorder and tourette syndrome: An epidemiological and pathway-based approach for gene discovery. Journal of the American Academy of Child and Adolescent Psychiatry, 49(8), 810-9, 819.e1-2.
Gurevich, I., Tamir, H., Arango, V., Dwork, A. J., Mann, J. J., & Schmauss, C. (2002). Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron, 34(3), 349–356.
Hanna, G. L. (2010). Schedule for obsessive-compulsive and other behavioral syndromes (SOCOBS). Ann Arbor, MI: University of Michigan.
Heils, A., Teufel, A., Petri, S., Stober, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996). Allelic variation of human serotonin transporter gene expression. Journal of Neurochemistry, 66(6), 2621–2624.
Hesse, S., Stengler, K., Regenthal, R., Patt, M., Becker, G. A., Franke, A., Knüpfer, H., Meyer, P. M., Luthardt, J., Jahn, I., Lobsien, D., Heinke, W., Brust, P., Hegerl, U., & Sabri, O. (2011). The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), 14(5), 606–617.
Honda, S., Nakao, T., Mitsuyasu, H., Okada, K., Gotoh, L., Tomita, M., Sanematsu, H., Murayama, K., Ikari, K., Kuwano, M., Yoshiura, T., Kawasaki, H., & Kanba, S. (2017). A pilot study exploring the association of morphological changes with 5-HTTLPR polymorphism in OCD patients. Annals of General Psychiatry, 16, 2-017-0126-6. eCollection 2017.
Howie, B. N., Donnelly, P., & Marchini, J. (2009). A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genetics, 5(6), e1000529.
Hu, X. Z., Lipsky, R. H., Zhu, G., Akhtar, L. A., Taubman, J., Greenberg, B. D., Xu, K., Arnold, P. D., Richter, M. A., Kennedy, J. L., Murphy, D. L., & Goldman, D. (2006). Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. American Journal of Human Genetics, 78(5), 815–826.
Iwamoto, K., & Kato, T. (2003). RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders. Neuroscience Letters, 346(3), 169–172.
Kaufman, J., Birmaher, B., Brent, D., Rao, U., Flynn, C., Moreci, P., Williamson, D., & Ryan, N. (1997). Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): Initial reliability and validity data. Journal of the American Academy of Child and Adolescent Psychiatry, 36(7), 980–988.
Leckman, J. F., Denys, D., Simpson, H. B., Mataix-Cols, D., Hollander, E., Saxena, S., Miguel, E. C., Rauch, S. L., Goodman, W. K., Phillips, K. A., & Stein, D. J. (2010). Obsessive-compulsive disorder: A review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V. Depression and Anxiety, 27(6), 507–527.
Leite, J., Hespanhol, R., & Buchpiguel, C. A. (2015). Molecular imaging in genetics. Neuroimaging Clinics of North America, 25(1), 17–29.
Lesch, K. P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (New York, N.Y.), 274(5292), 1527–1531.
Lestrade, L., & Weber, M. J. (2006). snoRNA-LBME-db, a comprehensive database of human H/ACA and C/D box snoRNAs. Nucleic Acids Research, 34(Database issue), D158–D162.
Li, M. X., Yeung, J. M., Cherny, S. S., & Sham, P. C. (2012). Evaluating the effective numbers of independent tests and significant p-value thresholds in commercial genotyping arrays and public imputation reference datasets. Human Genetics, 131(5), 747–756.
Lu, Z. X., Jiang, P., & Xing, Y. (2012). Genetic variation of pre-mRNA alternative splicing in human populations. Wiley Interdisciplinary Reviews RNA, 3(4), 581–592.
Lyddon, R., Dwork, A. J., Keddache, M., Siever, L. J., & Dracheva, S. (2013). Serotonin 2c receptor RNA editing in major depression and suicide. The World Journal of Biological Psychiatry : The Official Journal of the World Federation of Societies of Biological Psychiatry, 14(8), 590–601.
MacMaster, F. P. (2010). Translational neuroimaging research in pediatric obsessive-compulsive disorder. Dialogues in Clinical Neuroscience, 12(2), 165–174.
Magnotta, V. A., Harris, G., Andreasen, N. C., O'Leary, D. S., Yuh, W. T., & Heckel, D. (2002). Structural MR image processing using the BRAINS2 toolbox. Computerized Medical Imaging and Graphics : The Official Journal of the Computerized Medical Imaging Society, 26(4), 251–264.
Mak, L., Streiner, D. L., & Steiner, M. (2015). Is serotonin transporter polymorphism (5-HTTLPR) allele status a predictor for obsessive-compulsive disorder? A meta-analysis. Archives of Women's Mental Health, 18(3), 435–445.
Mattina, G. F., & Steiner, M. (2016). The need for inclusion of sex and age of onset variables in genetic association studies of obsessive-compulsive disorder: Overview. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 67, 107–116.
Meyer-Lindenberg, A., & Weinberger, D. R. (2006). Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nature Reviews. Neuroscience, 7(10), 818–827.
Molineaux, S. M., Jessell, T. M., Axel, R., & Julius, D. (1989). 5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system. Proceedings of the National Academy of Sciences of the United States of America, 86(17), 6793–6797.
National Institutes of Health. (2008). Novel interventions for neurodevelopmental disorders (R21/R33). Retrieved from http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-09-021.html
Niswender, C. M., Herrick-Davis, K., Dilley, G. E., Meltzer, H. Y., Overholser, J. C., Stockmeier, C. A., Emeson, R. B., & Sanders-Bush, E. (2001). RNA editing of the human serotonin 5-HT2C receptor. Alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 24(5), 478–491.
Pauls, D. L., Abramovitch, A., Rauch, S. L., & Geller, D. A. (2014). Obsessive-compulsive disorder: An integrative genetic and neurobiological perspective. Nature Reviews. Neuroscience, 15(6), 410–424.
Petersen, A. C., Crockett, L., Richards, M., & Boxer, A. (1988). A self-report measure of pubertal status: Reliability, validity and initial norms. Journal of Youth and Adolescence, 7(2), 117–133.
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006). Principal components analysis corrects for stratification in genome-wide association studies. Nature Genetics, 38(8), 904–909.
Rosenberg, D. R., & Keshavan, M. S. (1998). A.E. Bennett research award. Toward a neurodevelopmental model of obsessive-compulsive disorder. Biological Psychiatry, 43(9), 623–640.
Rutter, M., Bailey, A., Berument, S. K., Lord, C., & Pickles, A. (2003). Social communication questionnaire. Los Angeles, CA: Western Psychological Services.
Scahill, L., Riddle, M. A., McSwiggin-Hardin, M., Ort, S. I., King, R. A., Goodman, W. K., Cicchetti, D., & Leckman, J. F. (1997). Children's Yale-Brown obsessive compulsive scale: Reliability and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36(6), 844–852.
Sinopoli, V. M., Erdman, L., Burton, C. L., Park, L. S., Dupuis, A., Shan, J., Goodale, T., Li, B., Shaheen, S-M, Crosbie, J., Schachar, R. J., Arnold, P. D. (under review). Serotonin system genes and obsessive-compulsive trait dimensions in a population-based, pediatric sample: A genetic association study. Journal of Child Psychology and Psychiatry.
Sinopoli, V. M., Burton, C. L., Kronenberg, S., & Arnold, P. D. (2017). A review of the role of serotonin system genes in obsessive-compulsive disorder. Neuroscience and Biobehavioral Reviews, 80, 372–381.
Szeszko, P. R., MacMillan, S., McMeniman, M., Chen, S., Baribault, K., Lim, K. O., Ivey, J., Rose, M., Banerjee, S. P., Bhandari, R., Moore, G. J., & Rosenberg, D. R. (2004). Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder. The American Journal of Psychiatry, 161(6), 1049–1056.
Taylor, S. (2013). Molecular genetics of obsessive-compulsive disorder: A comprehensive meta-analysis of genetic association studies. Molecular Psychiatry, 18(7), 799–805.
Taylor, S. (2016). Disorder-specific genetic factors in obsessive-compulsive disorder: A comprehensive meta-analysis. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : The Official Publication of the International Society of Psychiatric Genetics, 171B(3), 325–332.
Voyiaziakis, E., Evgrafov, O., Li, D., Yoon, H. J., Tabares, P., Samuels, J., Wang, Y., Riddle, M. A., Grados, M. A., Bienvenu, O. J., Shugart, Y. Y., Liang, K. Y., Greenberg, B. D., Rasmussen, S. A., Murphy, D. L., Wendland, J. R., McCracken, J. T., Piacentini, J., Rauch, S. L., Pauls, D. L., Nestadt, G., Fyer, A. J., & Knowles, J. A. (2011). Association of SLC6A4 variants with obsessive-compulsive disorder in a large multicenter US family study. Molecular Psychiatry, 16(1), 108–120.
Walitza, S., Marinova, Z., Grunblatt, E., Lazic, S. E., Remschmidt, H., Vloet, T. D., & Wendland, J. R. (2014). Trio study and meta-analysis support the association of genetic variation at the serotonin transporter with early-onset obsessive-compulsive disorder. Neuroscience Letters, 580, 100–103.
Wang, Y., Liu, J., Huang, B. O., Xu, Y. M., Li, J., Huang, L. F., Lin, J., Zhang, J., Min, Q. H., Yang, W. M., & Wang, X. Z. (2015). Mechanism of alternative splicing and its regulation. Biomedical Reports, 3(2), 152–158.
Weissmann, D., van der Laan, S., Underwood, M. D., Salvetat, N., Cavarec, L., Vincent, L., Molina, F., Mann, J. J., Arango, V., & Pujol, J. F. (2016). Region-specific alterations of A-to-I RNA editing of serotonin 2c receptor in the cortex of suicides with major depression. Translational Psychiatry, 6(8), e878.
Wendland, J. R., Martin, B. J., Kruse, M. R., Lesch, K. P., & Murphy, D. L. (2006). Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Molecular Psychiatry, 11(3), 224–226.
Werry, T. D., Loiacono, R., Sexton, P. M., & Christopoulos, A. (2008). RNA editing of the serotonin 5HT2C receptor and its effects on cell signalling, pharmacology and brain function. Pharmacology & Therapeutics, 119(1), 7–23.
Wierenga, L. M., Bos, M. G. N., Schreuders, E., Kamp, F.v., Peper, J. S., Tamnes, C. K., & Crone, E. A. (2018). Unraveling age, puberty and testosterone effects on subcortical brain development across adolescence. Psychoneuroendocrinology, 91, 105–114.
Williams, M. T., Mugno, B., Franklin, M., & Faber, S. (2013). Symptom dimensions in obsessive-compulsive disorder: Phenomenology and treatment outcomes with exposure and ritual prevention. Psychopathology, 46(6), 365–376.
Wu, K., Hanna, G. L., Easter, P., Kennedy, J. L., Rosenberg, D. R., & Arnold, P. D. (2013). Glutamate system genes and brain volume alterations in pediatric obsessive-compulsive disorder: A preliminary study. Psychiatry Research, 211(3), 214–220.
Yücel, M., Wood, S. J., Wellard, R. M., Harrison, B. J., Fornito, A., Pujol, J., Velakoulis, D., & Pantelis, C. (2008). Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder. The Australian and New Zealand Journal of Psychiatry, 42(6), 467–477.
Funding
This work was supported by the National Institutes of Health (NIH) grants R01-MH101493, R01-MH085300, R01-MH085321, and R01-MH59299. Dr. Arnold receives support from the Alberta Innovates Health Solutions (AIHS) Translational Research Chair in Child and Youth Mental Health. Dr. Rosenberg receives support from the Lycaki-Young Fund, State of Michigan, Miriam L. Hamburger Endowed Chair of Child Psychiatry, Paul and Anita Strauss Endowment, Children’s Hospital of Michigan Foundation, and Donald and Mary Kosch Foundation. Vanessa Sinopoli received funding from the Canadian Institutes of Health Research (CIHR) Master’s Award: Frederick Banting and Charles Best Canada Graduate Scholarships, Ontario Graduate Scholarship (OGS), and the Hospital for Sick Children Restracomp Studentship.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to disclose.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Written and informed consent and assent was obtained for all participants. Each site received study approval from its Human Investigation Committee prior to recruitment of participants.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Highlights
• Significant effect of genotype-diagnosis interaction on ACC volume in females.
• Effect of HTR2C SNPs on ACC volume differs between OCD patients and controls.
• No significant genotype-diagnosis interaction found in males
Rights and permissions
About this article
Cite this article
Sinopoli, V.M., Erdman, L., Burton, C.L. et al. Serotonin system gene variants and regional brain volume differences in pediatric OCD. Brain Imaging and Behavior 14, 1612–1625 (2020). https://doi.org/10.1007/s11682-019-00092-w
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11682-019-00092-w